Dietmar W. Siemann

Dietmar W. Siemann

Auto-generated profile, based on publicly available information

Dietmar W. Siemann

Department of Radiation Oncology, University of Florida, Gainesville, Florida

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2011 in International Journal of Radiation Biology
Verified
Journal Article
Open access
PDF file
LBLotte B. Bertelsen
Lotte B. Bertelsen
YSYuan Shen
Yuan Shen
TNThomas Nielsen
Thomas Nielsen
HSHans Stødkilde-Jørgensen
Hans Stødkilde-Jørgensen
GLG. Kenneth Lloyd
G. Kenneth Lloyd
MHMichael Robert Horsman
Michael Robert Horsman
Purpose: This study investigated the anti-tumour effects of the novel vascular disrupting agent plinabulin (NPI-2358) when given alone or combined with radiation. Materials and methods: Foot implanted C3H mammary carcinomas or leg implanted KHT sarcomas were used, with plinabulin injected intraperitoneally. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) measurements were made with gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA) on a 7-tesla magnet. Treatment response was assessed using regrowth delay (C3H tumours), clonogenic survival (KHT sarcomas) or histological estimates of necrosis for both models. Results: Plinabulin (7.5 mg/kg) significantly reduced the initial area under curve (IAUC) and the transfer constant (Ktrans) within 1 hour after injection, reaching a nadir at 3 h, but returning to normal within 24 h. A dose-dependent decrease in IAUC and Ktrans, was seen at 3 h. No significant anti-tumour effects were observed in the C3H tumours until doses of 12.5 mg/kg were achieved, but started at 1.5 mg/kg in the KHT sarcoma. Irradiating tumours 1 h after injecting plinabulin enhanced response in both models. Conclusions: Plinabulin induced a time- and dose-dependent decrease in tumour perfusion. The KHT sarcoma was more sensitive than the C3H tumour to the anti-tumour effects of plinabulin, while radiation response was enhanced in both models.

1 March 2023 in Biophysics Reviews
Verified
Journal Article
Open access
PDF file
BRBing Ren
Bing Ren
ZJZhihua Jiang
Zhihua Jiang
WMWalter Lee Murfee
Walter Lee Murfee
AKAdam J. Katz
Adam J. Katz
DSDietmar Siemann
Dietmar Siemann
YHYong Huang
Yong Huang
Vascularization is essential for realizing thick and functional tissue constructs that can be utilized for in vitro study platforms and in vivo grafts. The vasculature enables the transport of nutrients, oxygen, and wastes and is also indispensable to organ functional units such as the nephron filtration unit, the blood–air barrier, and the blood–brain barrier. This review aims to discuss the latest progress of organ-like vascularized constructs with specific functionalities and realizations even though they are not yet ready to be used as organ substitutes. First, the human vascular system is briefly introduced and related design considerations for engineering vascularized tissues are discussed. Second, up-to-date creation technologies for vascularized tissues are summarized and classified into the engineering and cellular self-assembly approaches. Third, recent applications ranging from in vitro tissue models, including generic vessel models, tumor models, and different human organ models such as heart, kidneys, liver, lungs, and brain, to prevascularized in vivo grafts for implantation and anastomosis are discussed in detail. The specific design considerations for the aforementioned applications are summarized and future perspectives regarding future clinical applications and commercialization are provided.

1 January 1998 in Radiation Oncology Investigations
Verified
Journal Article
Closed access
PKPeter C. Keng
Peter C. Keng
DSDietmar W. Siemann
Dietmar W. Siemann

10 March 2006
Verified
Book Chapter
Closed access
PDF file
WSWenyin Shi
Wenyin Shi
MHMichael Robert Horsman
Michael Robert Horsman
DSDietmar W. Siemann
Dietmar W. Siemann

1 January 1991
Verified
Book Chapter
Closed access
JWJ.P. Williams
J.P. Williams
DSD.W. Siemann
D.W. Siemann

1 June 2020
Verified
Conference Paper
Closed access
ASAriana D. Suarez-Martinez
Ariana D. Suarez-Martinez
MSMarc Sole-Gras
Marc Sole-Gras
SDSamantha S. Dykes
Samantha S. Dykes
ZWZachary R. Wakefield
Zachary R. Wakefield
KBKevin Bauer
Kevin Bauer
WMWalter L. Murfee
Walter L. Murfee
A challenge in cancer research is the lack of a physiologically responsive in vitro model that allows for the investigation of cancer cells in a tissue-like environment. A model that enables real-time investigation of cancer cell migration, fate, and function during microvascular network growth does not currently exist. While current models such as 2D in vitro models or microfluidic systems incorporate real-time cell tracking and multiple cell types, they do not mimic the complexity of intact networks and tissue environments. The objective of this study was to establish a novel tumor-microvasculature model by demonstrating the feasibility of bioprinting cancer cells onto excised mouse mesometrium tissues. Prelabeled DiI mouse breast cancer (4T1) cells were inkjet-printed onto mouse mesometrium tissues. The cell ink for printing comprised 2% Na-alginate mixed in minimum essential media with 1% PenStrep (MEM) containing 15 million 4T1 cells. A single cancer cell spot per tissue was created by printing 10 drops of cell ink in the same location. MEM was added on top of tissue 30 seconds after printing and then incubated for 5 minutes before being plated into 6-well plates containing MEM supplemented with 20% serum. Tissues were cultured for 5 days, with media being changed every day. The spot of DiI+ cells was imaged every 24 hours to then quantify cell number and area for Day 0, 1, and 2. At Day 2 or 5, tissues were fixed in methanol and labeled with platelet endothelial cell adhesion molecule (PECAM), and E-cadherin, to identify endothelial cells and cancer cells, respectively. Co-localization of DAPI+ nuclei confirmed that DiI+ cells remained intact post-printing. Printed DiI+ 4T1 cells also remained viable after printing on Day 0 and after culture on Day 5. Time-lapse imaging over 5 days in culture enabled tracking of cell motility and proliferation. The number of cells (Day 0: 159 +/- 40, Day 1: 370 +/- 78, Day 2: 889 +/- 184, Day 5: 18,031 +/- 1,695) and cell area (Day 0: 0.72 +/- 0.19, Day 1: 1.89 +/- 0.33, Day 2: 2.92 +/- 0.44, Day 5: 5.93 +/- 0.75 mm2) were significantly increased over time. Moreover, a proliferation assay of anti-BrdU on Day 2 also highlighted that a subset of E-cadherin+ cells are in the S-phase of the cell cycle, contributing to the increase in cell number and cell area. Also, microvessels in the tissue were angiogenic evident by PECAM+ sprouts. These results corroborate that cancer cells are mobile and proliferative in this novel ex vivo model. Further, they demonstrate the potential for bioprinting cancer cells onto live, intact tissues to investigate cancer dynamics within a physiologically relevant microenvironment. Citation Format: Ariana D. Suarez-Martinez, Marc Sole-Gras, Samantha S. Dykes, Zachary R. Wakefield, Kevin Bauer, Arinola Lampejo, Dietmar W. Siemann, Yong Huang, Walter L. Murfee. A novel tumor microenvironment model that combines bioprinting and tissue culture to investigate cancer cell and microvascular interactions [abstract]. In: Proceedings of the AACR Special Conference on the Evolving Landscape of Cancer Modeling; 2020 Mar 2-5; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2020;80(11 Suppl):Abstract nr A23.